198 related articles for article (PubMed ID: 34152830)
1. Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from
Reeder SM; Bah MA; Tursi NJ; Brooks RC; Patel A; Esquivel R; Eaton A; Jhun H; Chu J; Kim K; Xu Z; Zavala F; Weiner DB
Infect Immun; 2021 Sep; 89(10):e0072820. PubMed ID: 34152830
[TBL] [Abstract][Full Text] [Related]
2. Irradiated sporozoite vaccination induces sex-specific immune responses and protection against malaria in mice.
Vom Steeg LG; Flores-Garcia Y; Zavala F; Klein SL
Vaccine; 2019 Jul; 37(32):4468-4476. PubMed ID: 31262583
[TBL] [Abstract][Full Text] [Related]
3. Importance of the Immunodominant CD8
Gibbins MP; Müller K; Glover M; Liu J; Putrianti ED; Bauza K; Reyes-Sandoval A; Matuschewski K; Silvie O; Hafalla JCR
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32719159
[TBL] [Abstract][Full Text] [Related]
4. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
Schwenk R; DeBot M; Porter M; Nikki J; Rein L; Spaccapelo R; Crisanti A; Wightman PD; Ockenhouse CF; Dutta S
PLoS One; 2014; 9(10):e111020. PubMed ID: 25343487
[TBL] [Abstract][Full Text] [Related]
5. Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.
Porter MD; Nicki J; Pool CD; DeBot M; Illam RM; Brando C; Bozick B; De La Vega P; Angra D; Spaccapelo R; Crisanti A; Murphy JR; Bennett JW; Schwenk RJ; Ockenhouse CF; Dutta S
Clin Vaccine Immunol; 2013 Jun; 20(6):803-10. PubMed ID: 23536694
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection.
Foquet L; Hermsen CC; van Gemert GJ; Van Braeckel E; Weening KE; Sauerwein R; Meuleman P; Leroux-Roels G
J Clin Invest; 2014 Jan; 124(1):140-4. PubMed ID: 24292709
[TBL] [Abstract][Full Text] [Related]
7. Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of
Kurtovic L; Wetzel D; Reiling L; Drew DR; Palmer C; Kouskousis B; Hanssen E; Wines BD; Hogarth PM; Suckow M; Jenzelewski V; Piontek M; Chan JA; Beeson JG
Front Immunol; 2021; 12():641421. PubMed ID: 33815393
[TBL] [Abstract][Full Text] [Related]
8. A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.
Sklar MJ; Maiolatesi S; Patterson N; Sedegah M; Limbach K; Teneza-Mora N; Chuang I; Hollis-Perry KM; Banania JG; Guzman I; Ganeshan H; Reyes S; Hollingdale MR; Wong M; Lindstrom A; Reyes A; Alcorta Y; Garver L; Bankard K; Belmonte A; Belmonte M; Huang J; Gowda K; Inoue S; Velasco R; Bergmann-Leitner E; Hutter J; Lee T; Adams N; Chaudhury S; Hunt D; Tamminga C; Berrie E; Bellamy D; Bittaye M; Ewer K; Diggs C; Soisson LA; Lawrie A; Hill A; Richie TL; Villasante E; Epstein JE; Duplessis CA
PLoS One; 2021; 16(9):e0256980. PubMed ID: 34495988
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein.
Wang LT; Pereira LS; Kiyuka PK; Schön A; Kisalu NK; Vistein R; Dillon M; Bonilla BG; Molina-Cruz A; Barillas-Mury C; Tan J; Idris AH; Francica JR; Seder RA
PLoS Pathog; 2021 Dec; 17(12):e1010133. PubMed ID: 34871332
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.
McCoy ME; Golden HE; Doll TA; Yang Y; Kaba SA; Zou X; Gerbasi VR; Burkhard P; Lanar DE
Malar J; 2013 Apr; 12():136. PubMed ID: 23607541
[TBL] [Abstract][Full Text] [Related]
11. Liver-Directed AAV8 Booster Vaccine Expressing
Shahnaij M; Iyori M; Mizukami H; Kajino M; Yamagoshi I; Syafira I; Yusuf Y; Fujiwara K; Yamamoto DS; Kato H; Ohno N; Yoshida S
Front Immunol; 2021; 12():612910. PubMed ID: 34248928
[TBL] [Abstract][Full Text] [Related]
12. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.
Kaba SA; McCoy ME; Doll TA; Brando C; Guo Q; Dasgupta D; Yang Y; Mittelholzer C; Spaccapelo R; Crisanti A; Burkhard P; Lanar DE
PLoS One; 2012; 7(10):e48304. PubMed ID: 23144750
[TBL] [Abstract][Full Text] [Related]
13. Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.
Tewari K; Flynn BJ; Boscardin SB; Kastenmueller K; Salazar AM; Anderson CA; Soundarapandian V; Ahumada A; Keler T; Hoffman SL; Nussenzweig MC; Steinman RM; Seder RA
Vaccine; 2010 Oct; 28(45):7256-66. PubMed ID: 20846528
[TBL] [Abstract][Full Text] [Related]
14. Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.
Hutchings CL; Birkett AJ; Moore AC; Hill AV
Infect Immun; 2007 Dec; 75(12):5819-26. PubMed ID: 17908809
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo inhibition of malaria parasite infection by monoclonal antibodies against Plasmodium falciparum circumsporozoite protein (CSP).
Livingstone MC; Bitzer AA; Giri A; Luo K; Sankhala RS; Choe M; Zou X; Dennison SM; Li Y; Washington W; Ngauy V; Tomaras GD; Joyce MG; Batchelor AH; Dutta S
Sci Rep; 2021 Mar; 11(1):5318. PubMed ID: 33674699
[TBL] [Abstract][Full Text] [Related]
16. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum.
Radin K; Clement F; Jongert E; Sterckx YG; Ockenhouse C; Regules J; Lemiale F; Leroux-Roels G
Malar J; 2016 Nov; 15(1):543. PubMed ID: 27825382
[TBL] [Abstract][Full Text] [Related]
18. Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.
Bettencourt P
Front Immunol; 2020; 11():190. PubMed ID: 32153565
[No Abstract] [Full Text] [Related]
19. Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria.
Yadava A; Nurmukhambetova S; Pichugin AV; Lumsden JM
J Infect Dis; 2012 May; 205(9):1456-63. PubMed ID: 22457289
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic Cleavage of the Plasmodium falciparum Circumsporozoite Protein Is a Target of Protective Antibodies.
Espinosa DA; Gutierrez GM; Rojas-López M; Noe AR; Shi L; Tse SW; Sinnis P; Zavala F
J Infect Dis; 2015 Oct; 212(7):1111-9. PubMed ID: 25762791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
